BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7511085)

  • 41. Epstein-Barr virus-transformed B cell lines present M. leprae antigens to T cells.
    Elferink BG; Ottenhoff TH; de Vries RR
    Scand J Immunol; 1985 Nov; 22(5):585-9. PubMed ID: 3001928
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
    Yamamoto M; Yano A
    J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls.
    Molberg O; Kett K; Scott H; Thorsby E; Sollid LM; Lundin KE
    Scand J Immunol; 1997 Sep; 46(3):103-9. PubMed ID: 9315123
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide.
    Brooks JM; Murray RJ; Thomas WA; Kurilla MG; Rickinson AB
    J Exp Med; 1993 Sep; 178(3):879-87. PubMed ID: 7688791
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Staining of celiac disease-relevant T cells by peptide-DQ2 multimers.
    Quarsten H; McAdam SN; Jensen T; Arentz-Hansen H; Molberg Ø ; Lundin KE; Sollid LM
    J Immunol; 2001 Nov; 167(9):4861-8. PubMed ID: 11673490
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Failure of Epstein-Barr virus-specific cytotoxic T lymphocytes to lyse B cells transformed with the B95-8 strain is mapped to an epitope that associates with the HLA-B8 antigen.
    Misko IS; Schmidt C; Honeyman M; Soszynski TD; Sculley TB; Burrows SR; Moss DJ; Burman K
    Clin Exp Immunol; 1992 Jan; 87(1):65-70. PubMed ID: 1370774
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.
    Dørum S; Qiao SW; Sollid LM; Fleckenstein B
    J Proteome Res; 2009 Apr; 8(4):1748-55. PubMed ID: 19239248
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human T cell receptor-gamma delta-expressing T-cell lines recognize MHC-controlled elements on autologous EBV-LCL that are not HLA-A, -B, -C, -DR, -DQ, or -DP.
    Lam V; DeMars R; Chen BP; Hank JA; Kovats S; Fisch P; Sondel PM
    J Immunol; 1990 Jul; 145(1):36-45. PubMed ID: 1694208
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Determining MHC restriction of T-cell responses.
    Larché M
    Methods Mol Med; 2008; 138():57-72. PubMed ID: 18615244
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance.
    Khanna R; Burrows SR; Steigerwald-Mullen PM; Thomson SA; Kurilla MG; Moss DJ
    Virology; 1995 Dec; 214(2):633-7. PubMed ID: 8553567
    [TBL] [Abstract][Full Text] [Related]  

  • 52. EBV-B cells as antigen presenting cells in characterization of the self/donor context of allorecognition by T lymphocytes.
    Drouet C; Arvieux C; Devouassoux G; Csopaki F; Chavanon O; Brichon PY; Letoublon C; Zarski JP; Barnoud D; Pison C
    Transpl Immunol; 1998 Dec; 6(4):209-15. PubMed ID: 10342734
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The T cell repertoire for recognition of a phylogenetically distant protein antigen. Peptide specificity and MHC restriction of staphylococcal nuclease-specific T cell clones.
    Finnegan A; Smith MA; Smith JA; Berzofsky J; Sachs DH; Hodes RJ
    J Exp Med; 1986 Sep; 164(3):897-910. PubMed ID: 2427638
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition.
    Sjöström H; Lundin KE; Molberg O; Körner R; McAdam SN; Anthonsen D; Quarsten H; Norén O; Roepstorff P; Thorsby E; Sollid LM
    Scand J Immunol; 1998 Aug; 48(2):111-5. PubMed ID: 9716100
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Celiac sprue: correlation with murine T cell responses to wheat gliadin components.
    Kagnoff MF; Austin RK; Johnson HC; Bernardin JE; Dietler MD; Kasarda DD
    J Immunol; 1982 Dec; 129(6):2693-7. PubMed ID: 6183341
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gliadin-reactive T cells in Italian children from preventCD cohort at high risk of celiac disease.
    Camarca A; Auricchio R; Picascia S; Fierro O; Maglio M; Miele E; Malamisura B; Greco L; Troncone R; Gianfrani C
    Pediatr Allergy Immunol; 2017 Jun; 28(4):362-369. PubMed ID: 28339124
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Presentation of Candida albicans and purified protein derivative soluble antigens by Epstein-Barr virus-transformed human lymphoblastoid B-cell lines.
    Reitnauer PJ; Brown LR; Hank JA; Sondel PM
    Cell Immunol; 1986 Apr; 99(1):196-208. PubMed ID: 3019572
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
    Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
    Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3).
    Burrows SR; Sculley TB; Misko IS; Schmidt C; Moss DJ
    J Exp Med; 1990 Jan; 171(1):345-9. PubMed ID: 1688611
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.
    de Waal Malefyt R; Haanen J; Spits H; Roncarolo MG; te Velde A; Figdor C; Johnson K; Kastelein R; Yssel H; de Vries JE
    J Exp Med; 1991 Oct; 174(4):915-24. PubMed ID: 1655948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.